Preliminary assessment of the side effects of some chemotherapy to treat malignant diseases of hematopoietic organs
- Author:
Nguyen Anh Tri
- Publication Type:Journal Article
- Keywords:
hematopoietic organs, chemotherapy
- MeSH:
drug therapy;
Hematinics;
Diseases;
Therapeutics;
adverse effects
- From:Journal of Practical Medicine
2003;450(4):49-51
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
From 1995 to 2002, 364 courses of chemotherapy with different regimens, almost gave various side effects such as leucopenia, thrombocytopenia, hypohemoglobin, increase of liver enzymes (SGOT, SGPT,…), enhance urea, creatinine level, nausea, alopecia… with different severity and incidence. The common regimans with more significant side effects were Doxorubicin + AraC (P3), MOPP (P2), CHDP (P1) and VAD (P4); the regimens AraC + Depersolon (P7), Hydrea + AraC (P6) and particularly Hydrea alone (P5) gave usually less side effects
